Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association

Arnold, Suzanne V., Bhatt, Deepak L., Barsness, Gregory W., Beatty, Alexis L., Deedwania, Prakash C., Inzucchi, Silvio E., Kosiborod, Mikhail, Leiter, Lawrence A. +4 more·2020·Circulation
DOI 10.1161/cir.0000000000000766

Cited by (309)

Items 301–309 of 309

  1. Diabetes Mellitus Duration and Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Prospective Cohort Study
    Ayesha Tariq, Zohra Bhatti, Amer Hayat Khan, Madeeha Laghari, Bandeh Ali Talpur, Muhammad Aamir, Khalid Hussain · 2026 · International Journal of Vascular Medicine
  2. Contemporary sirolimus-based stent platforms versus durable-polymer limus-eluting stents in patients with diabetes undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Jaehoon Kim, Michael Putra Nugroho, Jinpyo Hong · 2026 · Future Cardiology
  3. Impact of Diabetes on Outcomes of Contemporary PCI Guided by OCT vs Angiography
    Luise Gaede, Stephan S. Achenbach, Mohamed Marwan, Richard A. Shlofmitz, Franco Fabbiocchi, Fernando Alfonso, Paolo Canova, David M. Leistner, Jana R. Buccola, Robert McNutt et al. · 2026 · JACC: Cardiovascular Interventions
  4. Medication literacy and its associated factors among middle-aged and older patients with comorbid coronary heart disease and type 2 diabetes mellitus: a cross-sectional study
    Xiao Pan, Xili Zhao, Dai Yingqi, Jiaxin Wei · 2026 · Frontiers in Public Health
  5. Nomogram for predicting post-percutaneous coronary intervention restenosis in patients with coronary artery disease and diabetes: a retrospective study
    Ping Wang, Hongyu Peng, Qian Fan, Yuan Shan, Ning Yin · 2026 · PeerJ
  6. ОСОБЕННОСТИ РАННЕГО ПОСЛЕОПЕРАЦИОННОГО ПЕРИОДА И СТРУКТУРА ОСЛОЖНЕНИЙ АОРТОКОРОНАРНОГО ШУНТИРОВАНИЯ У ПАЦИЕНТОВ С ИБС И САХАРНЫМ ДИАБЕТОМ 2 ТИПА
    D. A. Mamaradzhapova, Talipova Yulduz Shavkatovna · 2026 · Central Asian Journal of Multidisciplinary Research and Management Studies
  7. Counterfactual Policy Learning for Personalized Treatment Using SGLT2 Inhibitors
    Dániel Benjámin Sándor, Ákos Németh, Balint Daroczy, Ferenc Sztanek, Mariann Harangi, Péter Antal · 2026 · medRxiv
  8. Sodium-glucose cotransporter-2 inhibitors and mortality and liver-related outcomes in patients with alcoholic cirrhosis, type 2 diabetes, and obesity
    Mohamad Mahdi Osman, Omar T. Sims, Dian Jung Chiang · 2026 · Annals of Hepatology
  9. Research Progress on the Effects of SGLT-2 Inhibitors on Surrogate Markers of Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    李芮 孟 · 2026 · Advances in Clinical Medicine